AusBiotech is pleased to welcome Ms Rosanne Hyland as Deputy Chief Executive Officer after serving as Business Manager and Chief Operating Officer for five years.
Over the past five years, Rosanne has led the day-to-day operations of AusBiotech, covering finance, human resources, IT/operations and events. She also served as Acting CEO for the six months until May 2024, providing steadfast leadership and continuity of the organisation.
Within her new capacity as Deputy CEO, Rosanne will continue to oversee day to day operations while also working closely with the CEO, Rebekah Cassidy, to embed member value in all parts of the organisation’s operations.
AusBiotech CEO Rebekah Cassidy said:
“I couldn’t be more pleased to confirm Rosanne as AusBiotech’s Deputy CEO. Since joining the organisation, I have been impressed by her genuine dedication to our members and her passion for the growth of Australia’s life sciences sector.”
“As Australia’s peak body representing our life sciences industry, AusBiotech is always focused on meeting its members’ needs. However, we also have an opportunity to continually find new ways to hear the voices of our 3000+ members and ensure our organisation is orientating its activities and actions toward their quickly evolving environment. Rosanne’s passion for our members’ success, coupled with her two decades of leadership, operational, and financial management expertise, perfectly position her to help as we do this.”
Newly appointed Deputy CEO Rosanne Hyland said:
“I am privileged to be taking on the role of Deputy CEO, working closely with Rebekah to provide member focused leadership cross our organisation and our sector. There’s no doubt that Australia’s life sciences industry is poised for future growth. Making sure we can hear member voice at speed to enable their success must be one of our highest priorities. Getting to do that with our hardworking AusBiotech team, including our fantastic membership engagement team, is an honour.”
About Rosanne Hyland
Rosanne Hyland is a senior executive with more than 20 year’s experience growing teams and leading the operations of large, complex organisations. She joined AusBiotech in 2019 as Business Manager, was appointed Chief Operating Officer in 2021 and served as Acting CEO for the period between December 2023 and May 2024. Prior to joining AusBiotech, Rosanne was General Manager of The Prince Hospitality Group for 15 years where she was responsible for 20 individual businesses, employing over 700 people.
